Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
出版年份 2012 全文链接
标题
Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
作者
关键词
-
出版物
SCHIZOPHRENIA BULLETIN
Volume 39, Issue 2, Pages 295-305
出版商
Oxford University Press (OUP)
发表日期
2012-08-28
DOI
10.1093/schbul/sbs082
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
- (2011) Debra L. Foley et al. ARCHIVES OF GENERAL PSYCHIATRY
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation
- (2011) M. De Hert et al. BRITISH JOURNAL OF PSYCHIATRY
- Association of the metabolic syndrome with physical activity performance in patients with schizophrenia
- (2011) D. Vancampfort et al. DIABETES & METABOLISM
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
- (2011) Lawrence Maayan et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Endogenic and Iatrogenic Diabetes Mellitus in Drug-naïve Schizophrenia: The Role of Olanzapine and its Place in the Psychopharmacological Treatment Algorithm
- (2011) Dan Cohen et al. NEUROPSYCHOPHARMACOLOGY
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- Life expectancy among persons with schizophrenia or bipolar affective disorder
- (2011) Thomas Munk Laursen SCHIZOPHRENIA RESEARCH
- Cardiovascular risk in a first-episode psychosis sample: A ‘critical period’ for prevention?
- (2011) Vivek H. Phutane et al. SCHIZOPHRENIA RESEARCH
- Twenty-five year mortality of a community cohort with schizophrenia
- (2010) Steve Brown et al. BRITISH JOURNAL OF PSYCHIATRY
- Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
- (2010) Mehrul Hasnain et al. Current Diabetes Reports
- MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study
- (2010) Ruud van Winkel et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The Metabolic Syndrome and Cardiovascular Risk
- (2010) Salvatore Mottillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia
- (2010) Davy Vancampfort et al. PSYCHIATRY RESEARCH
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
- (2010) Julio Bobes et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
- (2009) Mario Álvarez-Jiménez et al. CNS DRUGS
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis
- (2009) Swapna K. Verma et al. JOURNAL OF CLINICAL PSYCHIATRY
- Weight gain in antipsychotic-naive patients: a review and meta-analysis
- (2009) I. Tarricone et al. PSYCHOLOGICAL MEDICINE
- Physical activity and fitness in adolescents at risk for psychosis within the Northern Finland 1986 Birth Cohort
- (2009) J. Koivukangas et al. SCHIZOPHRENIA RESEARCH
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Body mass index (BMI) of drug-naïve psychotic adolescents based on a population of adolescent psychiatric inpatients
- (2008) Jaana Juutinen et al. EUROPEAN PSYCHIATRY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review
- (2008) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects
- (2008) Karen A. Graham et al. SCHIZOPHRENIA RESEARCH
- Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
- (2008) S SENGUPTA et al. SCHIZOPHRENIA RESEARCH
- Defining the Metabolic Syndrome in Children and Adolescents: Will the Real Definition Please Stand Up?
- (2007) Earl S. Ford et al. JOURNAL OF PEDIATRICS
- Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005
- (2007) Rebecca M. Capasso et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started